Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Dec 12;3(1):100762.
doi: 10.1016/j.jacadv.2023.100762. eCollection 2024 Jan.

The Hidden Benefits of Septal Myectomy: The Journey Toward a More Holistic Approach

Dermot Phelan  1 , John Symanski  1
Affiliations
Editorial

The Hidden Benefits of Septal Myectomy: The Journey Toward a More Holistic Approach

Dermot Phelan et al. JACC Adv. .
No abstract available

Keywords: hypertrophic cardiomyopathy; left ventricular outflow tract obstruction; septal myectomy; sexual health.

PubMed Disclaimer

Conflict of interest statement

The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Figures

None
Graphical abstract
See this image and copyright information in PMC

Comment on

  • doi: 10.1016/j.jacadv.2023.100763

References

    1. Nguyen A., Schaff H.V., Calderon-Rojas R., et al. Improvement in sexual dysfunction in patients with hypertrophic cardiomyopathy undergoing septal myectomy: a prospective study. JACC: Adv. 2024;3
    1. Palma C., David C., Fernandes R.M., et al. The sham effect of invasive interventions in chronic coronary syndromes: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2022;22:223. - PMC - PubMed
    1. Desai M.Y., Tower-Rader A., Szpakowski N., et al. Association of septal myectomy with quality of life in patients with left ventricular outflow tract obstruction from hypertrophic cardiomyopathy. JAMA Netw Open. 2022;5 - PMC - PubMed
    1. Olivotto I., Oreziak A., Barriales-Villa R., et al. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomized, double-blind, placebo-controlled, phase 3 trial. Lancet. 2020;396:759–769. - PubMed
    1. Lewis E.F., Claggett B.L., McMurray J.J.V., et al. Health-related quality of life outcomes in PARADIGM-HF. Circ Heart Fail. 2017;10 - PubMed

Publication types

LinkOut - more resources